|
gptkbp:instance_of
|
gptkb:virus
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Epstein-Barr_virus
|
|
gptkbp:appears_in
|
via oral mucosa
|
|
gptkbp:associated_with
|
gptkb:healthcare_organization
gptkb:systemic_lupus_erythematosus
gptkb:psychologist
gptkb:computer
gptkb:rheumatoid_arthritis
gptkb:nasopharyngeal_carcinoma
lymphoproliferative disorders
|
|
gptkbp:author
|
gptkb:Michael_Epstein
gptkb:Bert_Achong
gptkb:Yvonne_Barr
|
|
gptkbp:catch_rate
|
establishes lifelong infection
|
|
gptkbp:complications
|
hepatitis
thrombocytopenia
splenic rupture
|
|
gptkbp:discovered_by
|
gptkb:United_Kingdom
|
|
gptkbp:family
|
gptkb:Herpesviridae
|
|
gptkbp:full_name
|
gptkb:Epstein-Barr_virus
|
|
gptkbp:genus
|
gptkb:Lymphocryptovirus
|
|
gptkbp:hosts
|
gptkb:Person
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
EBV
|
|
gptkbp:incubation_period
|
4 to 6 weeks
|
|
gptkbp:is_compared_to
|
over 90% in adults
|
|
gptkbp:is_popular_in
|
common worldwide
|
|
gptkbp:is_vulnerable_to
|
no approved vaccine
|
|
gptkbp:origin
|
B cells
epithelial cells
|
|
gptkbp:propagation_method
|
saliva
|
|
gptkbp:replaced_by
|
Burkitt lymphoma cells
|
|
gptkbp:reproduction
|
in B lymphocytes
|
|
gptkbp:research_focus
|
autoimmune diseases
cancer biology
vaccine development
|
|
gptkbp:restoration
|
possible
|
|
gptkbp:seed_dispersal
|
double-stranded DNA
|
|
gptkbp:social_responsibility
|
gptkb:healthcare_organization
gptkb:battle
gptkb:Burkitt_lymphoma
blood test
infectious mononucleosis
ubiquitous in human populations
|
|
gptkbp:symptoms
|
fatigue
fever
sore throat
swollen lymph nodes
|
|
gptkbp:treatment
|
antivirals
supportive care
corticosteroids
exploring monoclonal antibodies
investigating antiviral therapies
studying immune modulation
|
|
gptkbp:type_of
|
latent and lytic phases
|
|
gptkbp:was_marked_by
|
gptkb:EBNA-Ig_G
EA-Ig G
VCA-Ig G
VCA-Ig M
|
|
gptkbp:year_created
|
gptkb:1964
|